MCM
MYOK

Moore Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Moore Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-64,393
Closed -$3.36M – 390
2019
Q3 		$3.36M Buy
64,393
+4,109
+7% +$219K 0.13% 176
2019
Q2 		$3.02M Buy
60,284
+41,084
+214% +$2M 0.07% 209
2019
Q1 		$998K Buy
+19,200
New +$885K 0.03% 238
2016
Q4 		– Sell
-50,000
Closed -$817K – 309
2016
Q3 		$817K Buy
+50,000
New +$903K 0.03% 159

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return